| Drug Name | Cobimetinib |
|---|---|
| Other Drug Names | Cobimetinib fumarate; Cotellic; GDC-0973; RG-7421; RO 5514041; XL-518 |
| Chemical Name | [3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]{3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl}methanone |
| Formula | C21H21F3IN3O2 |
| Mol. Wt. | 531.31 |
| CAS No. | 934660-93-2 |
| UNII | ER29L26N1X |
| Target-based Actions | MEK protein kinase inhibitor; MEK-1 protein kinase inhibitor; MEK-2 protein kinase inhibitor |
| ATC Codes | L01XE38 |
| Highest Status | 批准上市 |
| Originator Company | Genentech, Roche |
| Structure |
 |
Extended Information